Senectovia Medizinaltechnik AG has been acquired by a financial investor
In the context of succession in the ownership, a multi-family office has taken over Senectovia Medizinaltechnik AG. The owner of Senectovia has sold 100% of the shares and the two parties have agreed not to disclose the sale price.
Senectovia Medizinaltechnik AG is specialized in the distribution and maintenance of products for decubitus prophylaxis and therapy, patient mobility and obesity care. The product range includes medical mattresses and aids for patient positioning and mobilization. Thanks to the excellent service and high quality of its products, Senectovia has become the market leader in its core business in German-speaking Switzerland.
The buyer is a multi-family office that prefers to invest in mid-sized companies in healthcare and other industries. With this investor, Senectovia has gained a strong partner who will actively promote and further develop the company’s strategy and growth plans.
The previous owner, who has played a key role in shaping the company for over 20 years, will remain closely associated with Senectovia as a member of the Board of Directors, and will contribute his extensive industry experience to the management committee in order to provide the new investor with optimum support in implementing the initiated strategy.
Oaklins’ team in Switzerland supported the owner of Senectovia Medizinaltechnik AG during the entire sale process as exclusive M&A advisors. This included the preparation of the sale documents, the identification and approach of potential buyers, the supervision of the buy-side due diligence, as well as negotiations with several parties and support up to the signing and closing of the transaction.
Michael Lienhart
Owner, Senectovia Medizinaltechnik AG
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreDolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreNuzoa has acquired Agrofauna
Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.
Learn more